Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
- PMID: 33439300
- DOI: 10.1007/s00404-020-05951-2
Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update
Abstract
Background: Polycystic ovarian syndrome (PCOS) is the most prevalent metabolic disorder in reproductive-age women. It is indeed a multifactorial condition evidenced by ovarian dysfunction, hyperandrogenaemia, infertility, hormonal imbalance and chronic anovulation. Experimental evidence infers that PCOS women are prone to cardiovascular problems and insulin resistance.
Purpose: To furnish the details about the association of inflammatory markers in PCOS.
Design: An extensive literature search on PubMed, science direct and google scholar has been performed for articles about PCOS and inflammation in PCOS. A comprehensive analysis using original articles, reviews, systemic and meta-analysis was conducted for better understanding the relationship between inflammatory cytokines and PCOS.
Results: The inflammatory markers perform a substantial part in managing the functions of the ovary. Any disturbances in their levels can lead to ovarian dysfunction. Inflammatory markers are associated with PCOS pathogenesis. The interplay between inflammatory cytokines in the PCOS ovary strongly implies that inflammation is one of the most potent risk factors of PCOS.
Conclusion: Inflammatory markers have a significant role in regulating the ovary. This manuscript highlights the significance of metabolic and inflammatory markers with PCOS. Since PCOS is always considered as a metabolic disorder, researchers can also consider focusing on the relationship between the inflammatory markers in PCOS to establish a new treatment or management of the disease and to improve women's health.
Keywords: CRP; Cytokines; IL-6; Inflammation; PCOS; TNF-α.
Similar articles
-
Chronic Low Grade Inflammation in Pathogenesis of PCOS.Int J Mol Sci. 2021 Apr 6;22(7):3789. doi: 10.3390/ijms22073789. Int J Mol Sci. 2021. PMID: 33917519 Free PMC article. Review.
-
Evaluation of the pro-inflammatory cytokine tumor necrosis factor-α in adolescents with polycystic ovary syndrome.J Pediatr Adolesc Gynecol. 2014 Dec;27(6):356-9. doi: 10.1016/j.jpag.2014.01.104. Epub 2014 Sep 23. J Pediatr Adolesc Gynecol. 2014. PMID: 25256873 Free PMC article.
-
The role of cytokines in polycystic ovarian syndrome.Gynecol Endocrinol. 2013 Jun;29(6):536-40. doi: 10.3109/09513590.2012.760195. Epub 2013 Feb 1. Gynecol Endocrinol. 2013. PMID: 23368758 Review.
-
The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.Gynecol Endocrinol. 2015 Mar;31(3):225-8. doi: 10.3109/09513590.2014.976546. Epub 2014 Nov 6. Gynecol Endocrinol. 2015. PMID: 25373529
-
Polycystic Ovary Syndrome.Obstet Gynecol. 2018 Aug;132(2):321-336. doi: 10.1097/AOG.0000000000002698. Obstet Gynecol. 2018. PMID: 29995717 Review.
Cited by
-
Correlation and predictive value of systemic immune-inflammation index for dyslipidemia in patients with polycystic ovary syndrome.BMC Womens Health. 2024 Oct 17;24(1):564. doi: 10.1186/s12905-024-03405-4. BMC Womens Health. 2024. PMID: 39420320 Free PMC article.
-
The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review.Metabolites. 2023 Jan 14;13(1):129. doi: 10.3390/metabo13010129. Metabolites. 2023. PMID: 36677054 Free PMC article. Review.
-
Risks of metabolic syndrome in the ADVANCE and NAMSAL trials.Front Reprod Health. 2023 Sep 18;5:1133556. doi: 10.3389/frph.2023.1133556. eCollection 2023. Front Reprod Health. 2023. PMID: 37791109 Free PMC article.
-
Effects of high-protein diets on the cardiometabolic factors and reproductive hormones of women with polycystic ovary syndrome: a systematic review and meta-analysis.Nutr Diabetes. 2024 Feb 29;14(1):6. doi: 10.1038/s41387-024-00263-9. Nutr Diabetes. 2024. PMID: 38424054 Free PMC article. Review.
-
Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis.Front Endocrinol (Lausanne). 2023 Aug 10;14:1223768. doi: 10.3389/fendo.2023.1223768. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37635987 Free PMC article.
References
-
- Buvinic M, Médici A, Fernández E, Torres AC (2006) Gender differentials in health. Dis Control Prior Dev Ctries 2:195–210
-
- Jia G, Tao H, Xue Y et al (2018) Analysis of secreted peptidome from omental adipose tissue in polycystic ovarian syndrome patients. J Cell Physiol 233:5885–5894 - PubMed
-
- Louwers YV, Laven JSE (2020) The polycystic ovary syndrome (PCOS) BT—female reproductive dysfunction. In: Fauser BCJM (ed) Petraglia F. Springer International Publishing, Champaign, pp 1–23
-
- Vidya Bharathi R, Swetha S, Neerajaa J et al (2017) An epidemiological survey: effect of predisposing factors for PCOS in Indian urban and rural population. Middle East Fertil Soc J 22:313–316. https://doi.org/10.1016/j.mefs.2017.05.007 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous